Efficacy and Safety of Levetiracetam Versus Fosphenytoin in Adult Convulsive Status Epilepticus: An Open-Label Randomized Controlled Trial
Cureus · 31.10.2026
DOI: 10.7759/cureus.118916 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Cureus, erschienen am 31.10.2026. Verfasst von Md. Amirul Islam und 9 weiteren Autor:innen. Die Arbeit nennt 30 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Islam, M. A., Akhter, S., Urmi, M. I., Osman, M., Aurpa, N. N., Akter, J., Amin, S. M. A., Ahmed, K. G. U., Mahmud, R., & Abdullah, M. A. A. (2026). Efficacy and Safety of Levetiracetam Versus Fosphenytoin in Adult Convulsive Status Epilepticus: An Open-Label Randomized Controlled Trial. Cureus. https://doi.org/10.7759/cureus.118916
Vancouver
Islam MA, Akhter S, Urmi MI, Osman M, Aurpa NN, Akter J, et al. Efficacy and Safety of Levetiracetam Versus Fosphenytoin in Adult Convulsive Status Epilepticus: An Open-Label Randomized Controlled Trial. Cureus. 2026. doi:10.7759/cureus.118916
BibTeX
@article{Islam2026,
author = {Islam, Md. Amirul and Akhter, Sharmin and Urmi, Moushumi Islam and Osman, Mohammad and Aurpa, Nishat Nayla and Akter, Jahanara and Amin, S M Arafath and Ahmed, Kazi Gias Uddin and Mahmud, Reaz and Abdullah, Md. Ameer Abbas},
title = {Efficacy and Safety of Levetiracetam Versus Fosphenytoin in Adult Convulsive Status Epilepticus: An Open-Label Randomized Controlled Trial},
journal = {Cureus},
year = {2026},
doi = {10.7759/cureus.118916}
}
EUVIMED